Finlands Akademi
Finansieringsbeslut
 
Sökande / Kontakt person Färkkilä, Anniina
Organisation Helsingfors universitet
Projektets titel Discovery and therapeutic exploitation of DNA damage- induced vulnerabilities in immune microenvironment of high grade serous ovarian cancer
Beslutnr 322979
Beslutsdatum 06.05.2019
Finansierings period 01.09.2019 - 31.08.2021
Finansiering 141 932
WebFOCUS Report
Beskrivning av projektet
A key event in tumor progression is the establishment of an immunosuppressive milieu that prevents an effective attack by the immune system on the tumor. New cancer therapeutics targeting these mechanisms of immune evasion have emerged as a promising approach in multiple cancers. The aims of the study are to uncover the cell types and pathways that lead to immune evasion in ovarian cancer, and find novel ways to target these mechanisms with combination therapies. To this end, we are using a novel single-cell tumor tissue imaging technology, immune cell subpopulation gene expression analysis, modern artificial intelligence algorithms, and functional tumor-immune co-culture assays in a large set of >1500 ovarian cancer patients. With the proposed studies, we will discover the mechanisms of immune evasion in ovarian cancer, and design and implement an early phase clinical trial to select patients for novel combination therapies to improve the outcomes of ovarian cancer.